Current medical news and unique business news for anyone who cares about the healthcare industry.
Insider trading: Former Nasdaq Managing Director Donald Johnson has pleaded guilty to one count of securities fraud. Johnson was charged for insider trading, illicit deals that the Securities and Exchange Commission said came from advance knowledge of corporate leadership changes, earnings reports and forecasts, and regulatory approvals of pharmaceutical products. The SEC said Johnson even placed illegal trades through his work computer. Over three years, Johnson obtained $755,000 in illegal profits. Companies Johnson traded in included United Therapeutics (NASDAQ:UTHR). Three of Johnson’s illegal trades were in stock for PPD (NYSE:PPDI), a Wilmington, North Carolina-based clinical research organization. Read details of Johnson’s alleged actions in the SEC complaint here.
The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
Pfizer strategic partnership: Pfizer is the latest large pharmaceutical company to enter a strategic partnership with clinical research organizations. The company has entered into agreements with both Icon and Parexel to be preferred providers of clinical trial and pharmaceutical services.
Hopkins patient safety institute: Johns Hopkins University plans to use a $10 million gift to form a new patient safety institute.
Hot bioengineering areas: New Jersey Institute of Technology Atam Dhawan talks about the five hot spots where medicine and technology will converge.
Achoo! Another way men and women are different: A new study from Quest Diagnostics finds that men may have a greater risk of allergies than women. Quest claims it’s the largest study ever conducted on allergies in the United States.